Panasonic Introduces the Shoe Deodorizer: Deodorizes Your Shoes While You Sleep
Panasonic Corporation will begin selling a shoe deodorizer, the MS-DS100, equipped with "nanoe X" that generates 10 times(*2) more hydroxyl (OH) radicals than "nanoe" to remove unpleasant shoe odors in a simple way, on September 20, 2018 (in Japan only).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180810005082/en/
Panasonic shoe deodorizer MS-DS100 (Photo: Business Wire)
One of the common causes of unpleasant shoe odors is isovaleric acid, an odorous substance produced by foot sweat and bacteria. According to a survey(*3) Panasonic conducted with sneaker wearers, about 62% of those surveyed take some measures to remove shoe odors, but about half of them are not satisfied with the deodorizing methods they use.
The MS-DS100 utilizes Panasonic's original ion particles, "nanoe
X," to dissolve and eliminate unpleasant shoe odors(*1). When the
product is set in shoes and the switch turned on, "nanoe X" is generated
and spreads from six outlets to every corner of the shoes to remove
odors(*1) in the entire interior of the shoes from the heel to the toe.
There are two operation modes to choose from. The normal mode provides approximately five hours of operation, while the long mode runs for about seven hours to remove stubborn odors. Both modes cost less than 1 yen(*4) per use, so it is very economical. The MS-DS100 also operates on a mobile battery(*5) so it can be used at a place where there is no AC power outlet. The product comes with a stylish storage case. The case accommodates the cap sections that are inserted into shoes for use, so the product can be stored neatly in the entrance area or shoe cupboard.
With the MS-DS100 shoe deodorizer, Panasonic proposes an easy way to remove shoe odors and expects to create new market demand.
|Product name: Shoe Deodorizer|
|Product No.: MS-DS100|
|Suggested retail price: Open price|
|Launch date: September 20, 2018|
|Monthly production volume: 1,000 units|
|1.||Uses "nanoe X" to dissolve and eliminate shoe odors(*1)|
|2.||Economical operation with electricity cost of less than 1 yen(*4) per use. Also operates on a mobile battery(*5).|
|3.||Storage case provided with the product features a stylish design to look attractive when placed in an entrance area.|
For more details, please visit https://news.panasonic.com/global/topics/2018/60160.html
*1: Effect of deodorizing foot odors (isovaleric acid) adhered to shoes. Testing laboratory: Panasonic Corporation, Product Analysis Center. Testing method: 6-stage odor intensity measurement method in an about 10-m2 test room. Deodorizing method: Generation of "nanoe." Test result: Odor intensity decreased by 1.5 in 5 hours. Test result certificate issuing date: June 4, 2018. Test result certificate number: 1V332-180604-K01.
- Test results were not obtained under actual use conditions.
- Deodorizing effect varies depending on the ambient conditions (temperature, humidity), operating time, type of odor, and type of textile.
- Sensitivity to the deodorizing effect may vary from individual to individual.
*2: According to the results of Panasonic's measurement conducted based on the ESR method. Comparison between 480 billion "nanoe" particles/second and 4,800 billion "nanoe X" particles/second.
*3: According to the results of Panasonic's Internet survey conducted in June 2018 with males and females (N = 2,000) in their 10s to 60s
*4: Calculated based on the new electricity rate of 1 kWh = 27 yen (including tax)
*5: For normal mode, use a mobile battery with a capacity of 3,760 mAh
or more (rated output: 5.0 VDC, 1.8 A). For long mode, use a mobile
battery with a capacity of 5,000 mAh or more (rated output: 5.0 VDC, 1.8
A). Operation on a mobile battery cannot be guaranteed since the
operating time may differ depending on the usage conditions, environment
and other factors.
- Mobile battery is not supplied with the product.
"nanoe" technology site
Panasonic Introduces the Deodorizing Hanger - A New Way to Care for Your
Clothes Simply by Placing Them on a Hanger (Jul 03, 2017)
Panasonic Develops a High Performance Nano-sized Electrostatic Atomized
Water Particle "nanoe X" Device, Which Inhibits Pollen, Allergens, and
Odor (Nov 01, 2016)
Global Communications Department
Global PR Office
Click here to go to Media Contact form
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 10:49 | Pressemelding
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41 | Pressemelding
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42 | Pressemelding
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00 | Pressemelding
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07 | Pressemelding
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha